Buy or sell Caresyntax stock pre IPO via an EquityZen fund
Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.
About Caresyntax Stock
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.
Co-Founder and CEO
Chief Financial Officer